Puma Biotechnology, Inc. (PBYI)

6.11 -0.09 (-1.45%) USD  |  NASDAQ  |  Jan 09, 16:00
6.115 0.00 (0.00%) Pre-Market: 20:00
More

Puma Biotechnology Research and Development Expense (Annual): 54.94M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Nephros, Inc. 0.906M
ACADIA Pharmaceuticals, Inc. 303.25M
Vanda Pharmaceuticals, Inc. 74.43M
CorMedix, Inc. 3.942M
Relmada Therapeutics, Inc. 46.18M